All Stories

  1. Early predictors of carotid atherosclerosis in patients with type 2 diabetes mellitus

    Article • World Journal of Diabetes, October 2025, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Alexander E Berezin

  2. Astrocyte-derived exosomes captured with amyloid-β42 and BACE-1 proteins as a promising biomarker for cognitive impairment in hypertensive patients

    Article • American Journal of Hypertension, October 2025, Oxford University Press (OUP)

    Professor Alexander E Berezin

  3. Nrf2/ARE pathway agonist omaveloxolone attenuates adverse cardiac remodeling in pressure-induced cardiac dysfunction

    Article • Journal of Cardiovascular Pharmacology, October 2025, Wolters Kluwer Health

    Professor Alexander E Berezin

  4. Carbohydrate antigen 125: promising diagnostic biomarker in heart failure with preserved ejection fraction

    Article • Heart, August 2025, BMJ

    Professor Alexander E Berezin

  5. Digital health interventions for cardiac rehabilitation in stable coronary artery disease

    Article • European Journal of Preventive Cardiology, August 2025, Oxford University Press (OUP)

    Professor Alexander E Berezin

  6. Low Levels of Adropin Predicted New Incidents of Atrial Fibrillation in Patients with Heart Failure with Preserved Ejection Fraction

    Article • Biomolecules, August 2025, MDPI AG

    Professor Alexander E Berezin

  7. The Association of Adropin with Asymptomatic Coronary Calcification in Patients in Early Stages of Chronic Kidney Disease

    Article • International Journal of Molecular Sciences, August 2025, MDPI AG

    Professor Alexander E Berezin

  8. Metabolic Dysregulation of Hydrogen Sulfide as a Driver of Vascular Disease

    Article • Journal of Cardiovascular Pharmacology, August 2025, Wolters Kluwer Health

    Professor Alexander E Berezin

  9. Macrophage migration inhibitory factor (MIF): can functional insights pave the way for future therapeutics in cardiovascular diseases?

    Article • Expert Opinion on Therapeutic Targets, July 2025, Taylor & Francis

    Professor Alexander E Berezin

  10. The Association of Adropin with Asymptomatic Coronary Calcification in Patients with Early Stages of Chronic Kidney Disease

    Article • June 2025, MDPI AG

    Professor Alexander E Berezin

  11. Low levels of adropin are associated with acute kidney injury after decongestion in patients with acutely decompensated heart failure

    Article • Journal of Molecular and Cellular Cardiology Plus, June 2025, Elsevier

    Professor Alexander E Berezin

  12. Nutritional and immune-inflammatory indexes in risk stratification of heart failure with preserved ejection fraction

    Article • Minerva Cardiology and Angiology, June 2025, Edizioni Minerva Medica

    Professor Alexander E Berezin

  13. Serum Levels of Irisin Are Positively Associated with Improved Cardiac Function in Patients with Heart Failure with Reduced Ejection Fraction

    Article • Biomedicines, April 2025, MDPI AG

    Professor Alexander E Berezin

  14. Cognitive Impairment in Acute Decompensated Heart Failure

    Article • American Journal of Hypertension, April 2025, Oxford University Press (OUP)

    Professor Alexander E Berezin

  15. SEX DISPARITIES IN LONG-TERM CARDIOVASCULAR OUTCOMES IN COVID-19 DISCHARGE DURING ALPHA, DELTA AND OMICRON WAVES

    Article • Journal of the American College of Cardiology, April 2025, Elsevier

    Professor Alexander E Berezin

  16. Liquid Biopsy Biomarkers for Personalized Management in Heart Failure

    Article • March 2025, Taylor & Francis

    Professor Alexander E Berezin

  17. Regenerative Therapy with Extracellular Vesicles in Acute and Chronic Kidney Injury

    Article • March 2025, Taylor & Francis

    Professor Alexander E Berezin

  18. On MANTA vascular closure devices following veno arterial extracorporeal membrane oxygenation: Effectiveness and complications

    Article • World Journal of Cardiology, March 2025, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Alexander E Berezin

  19. Multifactorial management of complex comorbidity followed by heart failure, chronic kidney disease and type 2 diabetes mellitus: the way to overcome missed opportunities

    Article • Heart, March 2025, BMJ

    Professor Alexander E Berezin

  20. Predictive value of the systemic immune inflammation index in recurrence of atrial fibrillation after radiofrequency catheter ablation

    Article • World Journal of Cardiology, January 2025, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Alexander E Berezin

  21. Protective activity of adipose-derived stem cell extracellular vesicles in ischemia and/or reperfusion

    Article • World Journal of Stem Cells, January 2025, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Alexander E Berezin

  22. Irisin Predicts Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic Peptide

    Article • Biomolecules, December 2024, MDPI AG

    Professor Alexander E Berezin

  23. Deterioration of endothelial function as a risk factor for osteoporosis in patients with type 2 diabetes mellitus and MAFLD

    Article • Acta Cardiologica, December 2024, Taylor & Francis

    Professor Alexander E Berezin

  24. Predictors of Poor Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction and Low Levels of N-Terminal Pro-B-Type Natriuretic Peptide

    Article • November 2024, MDPI AG

    Professor Alexander E Berezin

  25. Predictors for Irreversibility of Contrast-Induced Acute Kidney Injury in Patients with Obesity After Contrast-Enhanced Computed Tomography Coronary Angiography

    Article • Advances in Therapy, November 2024, Springer Science + Business Media

    Professor Alexander E Berezin

  26. Sex Differences in Long-Term Cardiovascular Outcomes and Mortality After COVID-19 Hospitalization During Alpha, Delta and Omicron Waves

    Article • Journal of Clinical Medicine, November 2024, MDPI AG

    Professor Alexander E Berezin

  27. Circulating Cell-Free Nuclear DNA Predicted an Improvement of Systolic Left Ventricular Function in Individuals with Chronic Heart Failure with Reduced Ejection Fraction

    Article • Cardiogenetics, October 2024, MDPI AG

    Professor Alexander E Berezin

  28. The Silent Threat: A Retrospective Cohort Study on the Impact of Prediabetes on ST-Elevation Myocardial Infarction Survival—A Call to Action!

    Article • Biomedicines, September 2024, MDPI AG

    Professor Alexander E Berezin

  29. The Silent Threat: Prediabetes and Its Impact on Heart Attack Survival—A Call to Action!

    Article • September 2024, MDPI AG

    Professor Alexander E Berezin

  30. Circulating Cell-Free Nuclear DNAs Predicted an Improvement of Systolic Left Ventricular Function in Individuals with Chronic Heart Failure with Reduced Ejection Fraction

    Article • August 2024, MDPI AG

    Professor Alexander E Berezin

  31. Low Levels of Adropin Predict Adverse Clinical Outcomes in Outpatients with Newly Diagnosed Prediabetes after Acute Myocardial Infarction

    Article • Biomedicines, August 2024, MDPI AG

    Professor Alexander E Berezin

  32. Trajectory of Irisin as a Predictor of Kidney-Related Outcomes in Patients with Asymptomatic Heart Failure

    Article • Biomedicines, August 2024, MDPI AG

    Professor Alexander E Berezin

  33. Adropin Predicts Asymptomatic Heart Failure in Patients with Type 2 Diabetes Mellitus Independent of the Levels of Natriuretic Peptides

    Article • Diagnostics, August 2024, MDPI AG

    Professor Alexander E Berezin

  34. An overview of circulating and urinary biomarkers capable of predicting the transition of acute kidney injury to chronic kidney disease

    Article • Expert Review of Molecular Diagnostics, July 2024, Taylor & Francis

    Professor Alexander E Berezin

  35. Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

    Article • Frontiers in Pharmacology, June 2024, Frontiers

    Professor Alexander E Berezin

  36. Circulating Levels of erythrocytes-derived vesicles are associated with glucose control in type 2 diabetes mellitus patients with atrial fibrillation

    Article • European Journal of Preventive Cardiology, June 2024, Oxford University Press (OUP)

    Professor Alexander E Berezin

  37. Predictors of worsening kidney function and their relation to SGLT2 inhibitor dapagliflozin administration in type 2 diabetes mellitus patients with chronic heart failure

    Article • European Journal of Preventive Cardiology, June 2024, Oxford University Press (OUP)

    Professor Alexander E Berezin

  38. Natural bioactive ingredients as plausible anti-atherosclerotic agent: evidence and hope from calycosin

    Article • Acta Cardiologica, May 2024, Taylor & Francis

    Professor Alexander E Berezin

  39. Potential harm of midodrine in renal failure patients with concomitant heart failure with reduced ejection fraction

    Article • Acta Cardiologica, May 2024, Taylor & Francis

    Professor Alexander E Berezin

  40. Low serum irisin levels predicted newly atrial fibrillation in patients with any phenotypes of chronic heart failure

    Article • EP Europace, May 2024, Oxford University Press (OUP)

    Professor Alexander E Berezin

  41. Circulating levels of erythrocytes-derived vesicles related to poor glycaemia control in type 2 diabetes mellitus patients with atrial fibrillation

    Article • EP Europace, May 2024, Oxford University Press (OUP)

    Professor Alexander E Berezin

  42. PREDICTORS OF KIDNEY EVENTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CHRONIC HEART FAILURE PATIENTS

    Article • Journal of Hypertension, May 2024, Wolters Kluwer Health

    Professor Alexander E Berezin

  43. Methods to predict heart failure in diabetes patients

    Article • Expert Review of Endocrinology & Metabolism, April 2024, Taylor & Francis

    Professor Alexander E Berezin

  44. Low irisin levels predict acutely decompensated heart failure in type 2 diabetes mellitus patients

    Article • European Heart Journal Acute Cardiovascular Care, April 2024, Oxford University Press (OUP)

    Professor Alexander E Berezin

  45. Variable effect of exercise training programme on cardiovascular outcomes in high-genetic-risk individuals with diabetes

    Article • European Journal of Preventive Cardiology, March 2024, Oxford University Press (OUP)

    Professor Alexander E Berezin

  46. Plausible prediction of renoprotective effects of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney diseases

    Article • Journal of International Medical Research, February 2024, SAGE Publications

    Professor Alexander E Berezin

  47. Extracellular vesicles in heart failure

    Article • January 2024, Elsevier

    Professor Alexander E Berezin

  48. Diagnostic and predictive abilities of myokines in patients with heart failure

    Article • January 2024, Elsevier

    Professor Alexander E Berezin

  49. The Plausible Role of Vascular Adhesion Molecules in Cardiovascular Diseases

    Article • Cardiovascular Innovations and Applications, January 2024, Compuscript, Ltd.

    Professor Alexander E Berezin

  50. Rationale and design of the ESC Heart Failure III Registry – Implementation and discovery

    Article • European Journal of Heart Failure, November 2023, Wiley

    Professor Alexander E Berezin

  51. Predictors of Kidney Function Outcomes and Their Relation to SGLT2 Inhibitor Dapagliflozin in Patients with Type 2 Diabetes Mellitus Who Had Chronic Heart Failure

    Article • Advances in Therapy, November 2023, Springer Science + Business Media

    Professor Alexander E Berezin

  52. The effect of sglt-2 inhibitor dapagliflozin on adropin serum levels in patients with chronic heart failure and concomitant type 2 diabetes mellitus

    Article • European Heart Journal, November 2023, Oxford University Press (OUP)

    Professor Alexander E Berezin

  53. Early beta-blocker therapy improves in-hospital mortality of patients with non-ST-segment elevation myocardial infarction – a meta-analysis

    Article • International Journal of Cardiology, October 2023, Elsevier

    Professor Alexander E Berezin

  54. Cell-free DNA as a plausible biomarker of chronic kidney disease

    Article • Epigenomics, September 2023, Future Medicine

    Professor Alexander E Berezin

  55. Missed Opportunities in Implementation and Optimization of Lipid-Lowering Therapies in Very-High-Risk Patients Presenting with ST-Segment Elevation Myocardial Infarction

    Article • Journal of Clinical Medicine, August 2023, MDPI AG

    Professor Alexander E Berezin

  56. Myokine profile and glycemic control in type 2 diabetes mellitus patients with heart failure

    Article • Atherosclerosis, August 2023, Elsevier

    Professor Alexander E Berezin

  57. DAPAGLIFLOZIN MODULATES ADROPIN SERUM LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC HEART FAILURE

    Article • Journal of Hypertension, June 2023, Wolters Kluwer Health

    Professor Alexander E Berezin

  58. DECREASED SERUM LEVELS OF IRISIN PREDICTED HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

    Article • Journal of Hypertension, June 2023, Wolters Kluwer Health

    Professor Alexander E Berezin

  59. IMPROVEMENT OF PREDICTIVE UTILITY OF NATRIURETIC PEPTIDE FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION WITH APELIN IN TYPE 2 DIABETES MELLITUS PATIENTS

    Article • Journal of Hypertension, June 2023, Wolters Kluwer Health

    Professor Alexander E Berezin

  60. CAUSES OF AN UNFRIENDLY CLINICAL OUTCOME OF MYOCARDIAL INFARCTION AGGRAVATED BY CARDIOGENIC SHOCK: A SINGLE-CENTER RETROSPECTIVE STUDY

    Article • Kharkiv Surgical School, May 2023, Institute of General and Emergency Surgery Named after V.T. Zaitsev NAMS of Ukraine

    Professor Alexander E Berezin

  61. Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion

    Article • Biomedicines, May 2023, MDPI AG

    Professor Alexander E Berezin

  62. Editorial for the Special Issue “Biological Markers of Cardiovascular Diseases: Applications and Utility in Clinical Practice”

    Article • Applied Sciences, April 2023, MDPI AG

    Professor Alexander E Berezin

  63. Low Plasma Levels of Irisin Predict Acutely Decompensated Heart Failure in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure

    Article • Journal of Cardiovascular Development and Disease, March 2023, MDPI AG

    Professor Alexander E Berezin

  64. Adropin Predicts Chronic Kidney Disease in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure

    Article • Journal of Clinical Medicine, March 2023, MDPI AG

    Professor Alexander E Berezin

  65. Cardiac Hepatopathy: New Perspectives on Old Problems through a Prism of Endogenous Metabolic Regulations by Hepatokines

    Article • Antioxidants, February 2023, MDPI AG

    Professor Alexander E Berezin

  66. Lower Circulating Cell-Free Mitochondrial DNA Is Associated with Heart Failure in Type 2 Diabetes Mellitus Patients

    Article • Cardiogenetics, February 2023, MDPI AG

    Professor Alexander E Berezin

  67. The Impact of SGLT2 Inhibitor Dapagliflozin on Adropin Serum Levels in Men and Women with Type 2 Diabetes Mellitus and Chronic Heart Failure

    Article • Biomedicines, February 2023, MDPI AG

    Professor Alexander E Berezin

  68. Cardiac Reprogramming with Stem Cells: An Advanced Therapeutic Strategy in Advanced Heart Failure

    Article • January 2023, Springer Science + Business Media

    Professor Alexander E Berezin

  69. Regeneration des Herzens auf der Grundlage von Stammzellen: Gibt es einen Platz für Optimismus in der Zukunft?

    Article • January 2023, Springer Science + Business Media

    Professor Alexander E Berezin

  70. Pericarditis - Diagnosis and Management Challenges [Working Title]

    Article • January 2023, IntechOpen

    Professor Alexander E Berezin

  71. Myeloperoxidase and global longitudinal strain in prognostication of clinical events after ST segment elevation myocardial infarction

    Article • Ukrainian Therapeutical Journal, December 2022, Publishing Company VIT-A-POL

    Professor Alexander E Berezin

  72. Biomarkers in Heart Failure: From Research to Clinical Practice

    Article • Annals of Laboratory Medicine, December 2022, Annals of Laboratory Medicine

    Professor Alexander E Berezin

  73. EFFECTIVENESS OF ADDITION OF METFORMIN TO STATIN THERAPY FOR PRODIABETOGENIC CHANGES CORRECTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY

    Article • PROBLEMS OF ENDOCRINE PATHOLOGY, December 2022, V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU

    Professor Alexander E Berezin

  74. Interplay between Myokine Profile and Glycemic Control in Type 2 Diabetes Mellitus Patients with Heart Failure

    Article • Diagnostics, November 2022, MDPI AG

    Professor Alexander E Berezin

  75. Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus

    Article • Molecular Biomedicine, November 2022, Springer Science + Business Media

    Professor Alexander E Berezin

  76. Interview: Alexander E Berezin

    Article • EMJ Cardiology, October 2022, European Medical Group

    Professor Alexander E Berezin

  77. Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus

    Article • Cells, September 2022, MDPI AG

    Professor Alexander E Berezin

  78. The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure

    Article • Biomedicines, July 2022, MDPI AG

    Professor Alexander E Berezin

  79. Circulating levels of irisin and apelin predict heart failure with preserved ejection fraction in type 2 diabetes mellitus patients

    Article • Cardiovascular Research, June 2022, Oxford University Press (OUP)

    Professor Alexander E Berezin

  80. UTILITY OF IRISIN AND APELIN IN PREDICTION OF HEART FAILURE PHENOTYPES IN TYPE 2 DIABETES MELLITUS PATIENTS

    Article • Journal of Hypertension, June 2022, Wolters Kluwer Health

    Professor Alexander E Berezin

  81. Point-of-care heart failure platform: where are we now and where are we going to?

    Article • Expert Review of Cardiovascular Therapy, May 2022, Taylor & Francis

    Professor Alexander E Berezin

  82. Sodium-Glucose Co-transporter-2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Breakthrough in Improvement of Clinical Outcomes?

    Article • European Medical Journal, May 2022, European Medical Group

    Professor Alexander E Berezin

  83. Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus

    Article • Frontiers in Physiology, May 2022, Frontiers

    Professor Alexander E Berezin

  84. Elevated levels of apelin predict favorable clinical course of heart failure in type 2 diabetes mellitus patients

    Article • European Journal of Preventive Cardiology, May 2022, Oxford University Press (OUP)

    Professor Alexander E Berezin

  85. Predictive value of both irisin and apelin for heart failure with preserved ejection fraction in type 2 diabetes mellitus patients

    Article • European Journal of Preventive Cardiology, May 2022, Oxford University Press (OUP)

    Professor Alexander E Berezin

  86. Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement

    Article • Journal of Personalized Medicine, April 2022, MDPI AG

    Professor Alexander E Berezin

  87. Extracellular Vesicles and Thrombogenicity in Atrial Fibrillation

    Article • International Journal of Molecular Sciences, February 2022, MDPI AG

    Professor Alexander E Berezin

  88. Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients

    Article • Journal of Cardiovascular Development and Disease, January 2022, MDPI AG

    Professor Alexander E Berezin

  89. Vascular Functional Recovery and Reparation by Human Endothelial Progenitor Cells

    Article • January 2022, Springer Science + Business Media

    Professor Alexander E Berezin

  90. Vascular Functional Recovery and Reparation by Human Endothelial Progenitor Cells

    Article • January 2022, Springer Science + Business Media

    Professor Alexander E Berezin

  91. Reversibility of adverse cardiac remodeling in type 2 diabetes mellitus patients: focus on sodium-glucose cotransporter-2 inhibitors

    Article • Vessel Plus, January 2022, OAE Publishing

    Professor Alexander E Berezin

  92. Heart failure among patients with prediabetes and type 2 diabetes mellitus: diagnostic and predictive biomarkers: a narrative review

    Article • Journal of Laboratory and Precision Medicine, January 2022, AME Publishing Company

    Professor Alexander E Berezin

  93. Biomarker-Based Guideline-Directed Medical Therapy of Heart Failure: The Gap Between Guidelines and Clinical Practice

    Article • EMJ Cardiology, October 2021, European Medical Group

    Professor Alexander E Berezin

  94. Biomarker-Based Guideline-Directed Medical Therapy of Heart Failure: The Gap Between Guidelines and Clinical Practice

    Article • EMJ Cardiology, October 2021, European Medical Group

    Professor Alexander E Berezin

  95. Low ratio of serum levels of apelin and NT-pro-BRAIN natriuretic peptide predicted the development of heart failure with preserved ejection fraction among type 2 diabetes mellitus patients

    Article • Atherosclerosis, August 2021, Elsevier

    Professor Alexander E Berezin

  96. Challenging and opportunities in clinical implementation of circulating cardiac biomarkers in diabetes mellitus: the narrative review

    Article • AME Medical Journal, June 2021, AME Publishing Company

    Professor Alexander E Berezin

  97. Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication

    Article • Applied Sciences, May 2021, MDPI AG

    Professor Alexander E Berezin

  98. Shift of conventional paradigm of heart failure treatment: from angiotensin receptor neprilysin inhibitor to sodium–glucose co-transporter 2 inhibitors?

    Article • Future Cardiology, May 2021, Taylor & Francis

    Professor Alexander E Berezin

  99. Promising Novel Biomarkers in Cardiovascular Diseases

    Article • Applied Sciences, April 2021, MDPI AG

    Professor Alexander E Berezin

  100. Antigen-presenting cell-derived extracellular vesicles in accelerating atherosclerosis

    Article • Biomedical Research and Therapy, March 2021, Biomedical Research and Therapy

    Professor Alexander E Berezin

  101. Myokines and Heart Failure: Challenging Role in Adverse Cardiac Remodeling, Myopathy, and Clinical Outcomes

    Article • Disease Markers, January 2021, Hindawi Publishing Corporation

    Professor Alexander E Berezin

  102. Stem-Cell-Based Cardiac Regeneration: Is There a Place For Optimism in the Future?

    Article • January 2021, Springer Science + Business Media

    Professor Alexander E Berezin

  103. The Hormone-like Myokines Irisin as Novel Biomarker for Cardiovascular Risk Stratification”,

    Article • Pharmacophore, January 2021, Polaris

    Professor Alexander E Berezin

  104. The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy

    Article • Frontiers in Cardiovascular Medicine, December 2020, Frontiers

    Professor Alexander E Berezin

  105. Serendipity and thinking outside the box in cardiovascular research

    Article • AME Medical Journal, December 2020, AME Publishing Company

    Professor Alexander E Berezin

  106. Emerging Role of Adipocyte Dysfunction in Inducing Heart Failure Among Obese Patients With Prediabetes and Known Diabetes Mellitus

    Article • Frontiers in Cardiovascular Medicine, November 2020, Frontiers

    Professor Alexander E Berezin

  107. The role of single nucleotide polymorphism of val66met (rs6265) of the brain-derived neurotropic factor in formation of endpoints after st-segment elevation myocardial infarction

    Article • European Heart Journal, November 2020, Oxford University Press (OUP)

    Professor Alexander E Berezin

  108. Subclinical emotional distress predicts 6-month clinical outcomes after ST-segment elevation myocardial infarction

    Article • Future Cardiology, September 2020, Taylor & Francis

    Professor Alexander E Berezin

  109. Brain-derived neurotrophic factor gene polymorphism in post-ST-elevation myocardial infarction patients undergoing primary percutaneous intervention

    Article • Biomedical Research and Therapy, August 2020, Biomedical Research and Therapy

    Professor Alexander E Berezin

  110. Факторы неблагоприятного клинического исхода инфаркта миокарда, осложненного кардиогенным шоком: результаты одноцентрового ретроспективного исследования

    Article • Ukrainian Journal of Cardiology, August 2020, Chetverta Кhvylia

    Professor Alexander E Berezin

  111. Endothelial cell-derived extracellular vesicles in atherosclerosis: the emerging value for diagnosis, risk stratification and prognostication

    Article • Vessel Plus, June 2020, OAE Publishing

    Professor Alexander E Berezin

  112. Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers

    Article • Disease Markers, June 2020, Hindawi Publishing Corporation

    Professor Alexander E Berezin

  113. The Utility of New Biomarker-based Predictive Model for Clinical Outcomes Among ST-elevation Myocardial Infarction Patients

    Article • The Open Biomarkers Journal, May 2020, Bentham Science Publishers

    Professor Alexander E Berezin

  114. The predictive value of vascular endothelial growth factor-A gene polymorphism for clinical outcomes among acute ST-segment elevation myocardial infarction patients: A single center prospective study

    Article • Biomedical Research and Therapy, May 2020, Biomedical Research and Therapy

    Professor Alexander E Berezin

  115. Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review

    Article • Diabetes Therapy, May 2020, Springer Science + Business Media

    Professor Alexander E Berezin

  116. Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure

    Article • Frontiers in Cardiovascular Medicine, April 2020, Frontiers

    Professor Alexander E Berezin

  117. Altered adipocytokine profile predicts early stage of left ventricular remodeling in hypertensive patients with type 2 diabetes mellitus

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, March 2020, Elsevier

    Professor Alexander E Berezin

  118. Diagnostic and therapeutic value of micro-RNAs in inflammatory bowel disease

    Article • Biomedical Research and Therapy, February 2020, Biomedical Research and Therapy

    Professor Alexander E Berezin

  119. Emerging role of natriuretic peptides in diabetes mellitus: New approaches for risk stratification

    Article • Heart and Mind, January 2020, Medknow

    Professor Alexander E Berezin

  120. Emerging diagnostic and predictive utilities of natriuretic peptides in diabetes mellitus patients at high cardiovascular risk

    Article • Integrative Molecular Medicine, January 2020, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  121. Efficacy of fixed dose of triple combination of perindopril-indapamide-amlodipine in obese patients with moderate-to-severe arterial hypertension: an open-label 6-month study

    Article • Biomedical Research and Therapy, November 2019, Biomedical Research and Therapy

    Professor Alexander E Berezin

  122. P6603The predictive role of T786C single nucleotide polymorphism in endothelial no-synthase gene in late left ventricular remodeling after ST-segment elevation myocardial infarction

    Article • European Heart Journal, October 2019, Oxford University Press (OUP)

    Professor Alexander E Berezin

  123. Impaired function of fibroblast growth factor 23 / Klotho protein axis in prediabetes and diabetes mellitus: Promising predictor of cardiovascular risk

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, July 2019, Elsevier

    Professor Alexander E Berezin

  124. Circulating platelet-derived vesicle in atrial fibrillation

    Article • Annals of Clinical Hypertension, June 2019, Heighten Science Publications Corporation

    Professor Alexander E Berezin

  125. Altered signature of apoptotic endothelial cell-derived microvesicles predicts chronic heart failure phenotypes

    Article • Biomarkers in Medicine, June 2019, Future Medicine

    Professor Alexander E Berezin

  126. Platelet-derived vesicles: diagnostic and predictive value in cardiovascular diseases

    Article • Journal of Unexplored Medical Data, May 2019, OAE Publishing

    Professor Alexander E Berezin

  127. Platelet-Derived Vesicles in Hypertension: New Target for Risk Stratification?

    Article • Biomedical Journal of Scientific & Technical Research, May 2019, Biomedical Research Network, LLC

    Professor Alexander E Berezin

  128. Vascular Access Surgery - Tips and Tricks

    Article • April 2019, IntechOpen

    Professor Alexander E Berezin

  129. Endothelial Progenitor Cells: Novel Biological Marker for Risk Stratification in Arterial Hypertension?

    Article • Biomedical Journal of Scientific & Technical Research, February 2019, Biomedical Research Network, LLC

    Professor Alexander E Berezin

  130. Circulating vascular endothelial growth factor in ST-segment elevation myocardial infarction: from bench to bedside

    Article • Biological Markers and Guided Therapy, January 2019, Hikari, Ltd.

    Professor Alexander E Berezin

  131. Prognostication of clinical outcomes in diabetes mellitus: Emerging role of cardiac biomarkers

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, January 2019, Elsevier

    Professor Alexander E Berezin

  132. Dynamic changes of circulating vascular endothelial growth factor levels in ST-segment elevation myocardial infarction: Controversies in clinical interpretation

    Article • General Medicine Open, January 2019, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  133. Endothelial progenitor cell dysfunction in diabetes mellitus: new target for risk stratification and therapies?

    Article • Biological Markers and Guided Therapy, January 2019, Hikari, Ltd.

    Professor Alexander E Berezin

  134. Cellular care and extracellular vesicles therapies of heart failure

    Article • Biological Markers and Guided Therapy, January 2019, Hikari, Ltd.

    Professor Alexander E Berezin

  135. Platelet-derived vesicles in acute myocardial infarction

    Article • Clinical Research and Trials, January 2019, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  136. Endogenous vascular repair system in cardiovascular disease: The role of endothelial progenitor cells

    Article • Australasian Medical Journal, January 2019, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  137. Soluble Suppression of Tumorigenicity 2: A Role in BiomarkerGuided Therapy of Heart Failure

    Article • Journal of Cardiology and Therapy, January 2019, ACT Publishing Group

    Professor Alexander E Berezin

  138. Терапевтический потенциал L-аргинина при кардиоваскулярных заболеваниях

    Article • Ukrainian Medical Journal, January 2019, LLC MORION

    Professor Alexander E Berezin

  139. Elevated levels of circulating soluble ST2 at discharge predict late adverse ventricular remodeling in patients with ST-segment elevation myocardial infarction

    Article • Biomedical Research and Therapy, December 2018, Biomedical Research and Therapy

    Professor Alexander E Berezin

  140. The endothelial progenitor cell dysfunction in hypertension: the diagnostic and predictive values

    Article • Vessel Plus, September 2018, OAE Publishing

    Professor Alexander E Berezin

  141. Association of growth-differentiation factor-15 with the number of circulating proangiogenic endothelial progenitor cells in patients with type 2 diabetes mellitus

    Article • Biomedical Research and Therapy, July 2018, Biomedical Research and Therapy

    Professor Alexander E Berezin

  142. Neutrophil extracellular traps: The core player in vascular complications of diabetes mellitus

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, July 2018, Elsevier

    Professor Alexander E Berezin

  143. Emerging Role of Galectin-3 in Pulmonary Artery Hypertension

    Article • Modern Health Science, June 2018, Ideas Spread

    Professor Alexander E Berezin

  144. Reply to: Is serum uric acid a pretty accurate prognostic predictor of ST elevated acute coronary syndrome? Author: Alexander E. Berezin

    Article • International Journal of Cardiology, June 2018, Elsevier

    Professor Alexander E Berezin

  145. Possible Role of Soluble St2 in Pulmonary Artery Hypertension

    Article • Anatomy Physiology & Biochemistry International Journal, May 2018, Juniper Publishers

    Professor Alexander E Berezin

  146. Circulating biomarkers in heart failure: diagnostic and prognostic importance

    Article • Journal of Laboratory and Precision Medicine, April 2018, AME Publishing Company

    Professor Alexander E Berezin

  147. Stem Cells and Stem Cells / Precursors-Derived Extracellular Vesicles in Heart Failure: What is Better for Cardiac Regeneration?

    Article • Journal of Stem Cell and Regenerative Biology, March 2018, Ommega Online Publishers

    Professor Alexander E Berezin

  148. Is serum uric acid a pretty accurate prognostic predictor of ST elevated acute coronary syndrome?

    Article • International Journal of Cardiology, March 2018, Elsevier

    Professor Alexander E Berezin

  149. Effect of Thymol against Fungi Deteriorating Mural Paintings at Tell Basta Tombs, Lower Egypt

    Article • International Journal of Research Studies in Biosciences, January 2018, ARC Publications Pvt Ltd.

    Professor Alexander E Berezin

  150. Circulating Biomarkers in Heart Failure

    Article • January 2018, Springer Science + Business Media

    Professor Alexander E Berezin

  151. The role of progenitor endothelial cell dysfunction in arterial hypertension

    Article • Biological Markers and Guided Therapy, January 2018, Hikari, Ltd.

    Professor Alexander E Berezin

  152. Can C-reactive Protein Genetic Variants Identify Patients with Higher and Lower Cardiovascular Risk?

    Article • Journal of Clinical & Experimental Cardiology, January 2018, OMICS Publishing Group

    Professor Alexander E Berezin

  153. Is Galectin-3 a Prognosticator of Severity and Clinical Outcomes of Pulmonary Artery Hypertension?

    Article • ARC Journal of Cardiology, January 2018, ARC Publications Pvt Ltd.

    Professor Alexander E Berezin

  154. The endothelial progenitor cell dysfunction in type 2 diabetes mellitus: the link with heart failure developing

    Article • Biological Markers and Guided Therapy, January 2018, Hikari, Ltd.

    Professor Alexander E Berezin

  155. The Endothelial Progenitor Cell Dysfunction in Type 2 Diabetes Mellitus: The Link with Heart Failure Developing

    Article • Journal of Diabetic Complications & Medicine, January 2018, OMICS Publishing Group

    Professor Alexander E Berezin

  156. Progenitor Endothelial Cells in Pulmonary Arterial Hypertension

    Article • Journal of General Practice, January 2018, OMICS Publishing Group

    Professor Alexander E Berezin

  157. Challenging role of neutrophil extracellular traps in vascular complications of diabetes mellitus

    Article • Integrative Molecular Medicine, January 2018, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  158. The Impact of Endothelial Progenitor Cell Dysfunction in Heart Failure “Obesity Paradox”

    Article • La Prensa Medica, January 2018, OMICS Publishing Group

    Professor Alexander E Berezin

  159. The Impact of Endothelial Progenitor Cell Dysfunction in Heart Failure “Obesity Paradox”

    Article • La Prensa Medica, January 2018, OMICS Publishing Group

    Professor Alexander E Berezin

  160. The obesity phenotypes: emerging role of cardiac biomarkers

    Article • Diabetes Updates, January 2018, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  161. Promising utilities of growth differentiation factor 15 in cardiovascular diseases

    Article • Biological Markers and Guided Therapy, January 2018, Hikari, Ltd.

    Professor Alexander E Berezin

  162. Growth Differentiation Factor 15 As Promising Biomarker Of Poor Prognosis In Heart Failure

    Article • Journal of Cardiology and Therapy, January 2018, ACT Publishing Group

    Professor Alexander E Berezin

  163. Pattern of Micro Vesicles in Heart Failure: Novel Biomarker of Endothelial Dysfunction and Vascular Reparation

    Article • Biomarkers Journal, January 2018, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  164. Enterococcus faecium L-3 in Eradication of Helicobacter pylori: In-vivo and In-vitro

    Article • International Journal of Clinical & Medical Microbiology, October 2017, Graphy Publications

    Professor Alexander E Berezin

  165. Serum uric acid as a metabolic regulator of endothelial function in heart failure

    Article • September 2017, Peertechz.com

    Professor Alexander E Berezin

  166. [BP.04.06] CIRCULATING ENDOTHELIAL-DERIVED APOPTOTIC MICROPARTICLES TO MONONUCLEAR PROGENITOR CELLS RATIO AS A PREDICTOR OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ACUTELY DECOMPENSATED HEART

    Article • Journal of Hypertension, September 2017, Wolters Kluwer Health

    Professor Alexander E Berezin

  167. Dysfunction of Endothelial Cell Precursors in Heart Failure Development

    Article • Biomedical Journal of Scientific & Technical Research, August 2017, Biomedical Research Network, LLC

    Professor Alexander E Berezin

  168. Uric Acid in Heart Failure: Controversy Factor in The Multiple Pathogenesis of The Disease

    Article • Biomedical Journal of Scientific & Technical Research, August 2017, Biomedical Research Network, LLC

    Professor Alexander E Berezin

  169. P6493Non-classical phenotypes of circulating endothelial cell-derived progenitor cells predicts asymptomatic atherosclerosis metabolically unhealthy obesity

    Article • European Heart Journal, August 2017, Oxford University Press (OUP)

    Professor Alexander E Berezin

  170. Up-to-date clinical approaches of biomarkers’ use in heart failure

    Article • Biomedical Research and Therapy, June 2017, Biomedical Research and Therapy

    Professor Alexander E Berezin

  171. 1314Endothelial progenitor cells and apoptotic endothelial cell-derived microparticle ratio predicts atrial fibrillation in chronic heart failure

    Article • EP Europace, June 2017, Oxford University Press (OUP)

    Professor Alexander E Berezin

  172. Article • May 2017, Aperito Online Publishing Private Limited

    Professor Alexander E Berezin

  173. Abstracts

    Article • European Journal of Heart Failure, May 2017, Wiley

    Professor Alexander E Berezin

  174. Are inflammatory cytokines and angiogenic factors a predictive biomarker of diabetes retinopathy?

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, May 2017, Elsevier

    Professor Alexander E Berezin

  175. The Controversial Role of Osteopontin in Vascular Calcification: From Bench to Bedside

    Article • MOJ Proteomics & Bioinformatics, April 2017, MedCrave Group LLC

    Professor Alexander E Berezin

  176. Abstract Book: ISEV2017

    Article • Journal of Extracellular Vesicles, April 2017, Taylor & Francis

    Professor Alexander E Berezin, Dr Muhammad Nawaz

  177. Is advanced Coupling Methods best fitted in Biosensing of Microparticles?

    Article • April 2017, Heighten Science Publications Corporation

    Professor Alexander E Berezin

  178. Article • Diabetes Research and Treatment Open Access, February 2017, Aperito Online Publishing Private Limited

    Professor Alexander E Berezin

  179. Biosensing of Circulating Apoptotic Endothelial Cell Micro particles: The Impact in Risk Stratification of Obesity

    Article • February 2017, MedCrave Group LLC

    Professor Alexander E Berezin

  180. Circulating apoptotic endothelial cell-derived microparticles are predicted metabolically unhealthy obesity

    Article • Biomedical Research and Therapy, January 2017, Biomedical Research and Therapy

    Professor Alexander E Berezin

  181. The number of red blood cell-derived microparticles in predicting periprocedural adverse effects in acute STsegment elevation myocardial infarction patients

    Article • Journal of Clinical Trials in Cardiology, January 2017, Symbiosis Group

    Professor Alexander E Berezin

  182. Assessment of nephroprotective action of angiotensin-converting enzyme inhibitor ramipril in patients with chronic glomerulonephritis

    Article • Biological Markers and Guided Therapy, January 2017, Hikari, Ltd.

    Professor Alexander E Berezin

  183. Biosensing of periprocedural events in acute ST-segment elevation myocardial infarction patients with the erythrocyte-derived microparticles

    Article • Cardiovascular Disorders and Medicine, January 2017, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  184. "Obesity Paradox" in Heart Failure: The Possible Role of Progenitor Endothelial Cell Dysfunction

    Article • Cell & Developmental Biology, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  185. Microparticles in Chronic Heart Failure

    Article • January 2017, Elsevier

    Professor Alexander E Berezin

  186. The predictive value of circulating apoptotic endothelial cell-derived micro particles in obesity progression?

    Article • Biological Markers and Guided Therapy, January 2017, Hikari, Ltd.

    Professor Alexander E Berezin

  187. Number of Circulating Endothelial Progenitor Cells as a Predictive Biomarker of Heart Failure

    Article • Journal of Clinical Epigenetics, January 2017, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  188. The Growth/Differentiation Factor-15 in Chronic Heart Failure: New Challenge in Biomarker-Guided Therapy?

    Article • Translational Biomedicine, January 2017, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  189. The Role of Vistafin in Diabetes-Induced Impairment of Endothelial Repair System

    Article • Translational Biomedicine, January 2017, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  190. The role of circulating endothelial progenitor cell dysfunction in pregnancy-induced hypertension

    Article • Biological Markers and Guided Therapy, January 2017, Hikari, Ltd.

    Professor Alexander E Berezin

  191. Preconditioned Endothelial Progenitor Cells as Biomarker of Vascular Reparation?

    Article • Insights in Biomedicine, January 2017, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  192. Novel Biomarkers in Prediction of Heart Failure Related Outcomes: From Bench to Bedside

    Article • Internal Medicine Open Access, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  193. Current understanding of the role of new cardiac biomarkers in prediction of heart failure

    Article • Biological Markers and Guided Therapy, January 2017, Hikari, Ltd.

    Professor Alexander E Berezin

  194. The placental cell-derived exosomes as a promising predictive biomarker of preeclampsia in symptomatic pregnancies

    Article • Biological Markers and Guided Therapy, January 2017, Hikari, Ltd.

    Professor Alexander E Berezin

  195. Hypertension in Pregnancy: The Role of Circulating Endothelial Progenitor Cell Dysfunction

    Article • Journal of Hypertension Open Access, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  196. Are Placental Cell-Derived Exosomes a Predictive Biomarker of Preeclampsia?

    Article • Medicinal Chemistry, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  197. Are Novel Cardiac Biomarkers Required in Prediction of Heart Failure Development and Outcomes?

    Article • ARC Journal of Cardiology, January 2017, ARC Publications Pvt Ltd.

    Professor Alexander E Berezin

  198. Could be Used an Immune Phenotypes of Circulating Endothelial Progenitor Cells as a Biomarker of Cardiovascular Disease?

    Article • ARC Journal of Cardiology, January 2017, ARC Publications Pvt Ltd.

    Professor Alexander E Berezin

  199. The Advanced Bright-field Light Optical Polarization Microscopy: Novel Coupling Method for Detection of Micro Vesicles

    Article • Journal of Medical Diagnostic Methods, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  200. Growth-Differentiation Factor-15 as Additional Prognostic Biomarkers in Heart Failure

    Article • Journal of Postgenomics Drug & Biomarker Development, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  201. The Controversial Role of Serum Uric Acid in Cardiovascular Diseases

    Article • THE ULUTAS MEDICAL JOURNAL, January 2017, ScopeMed International Medical Journal Management and Indexing System

    Professor Alexander E Berezin

  202. The Endothelial Progenitor Cell Dysfunction: The Missed Predictor of Heart Failure Outcomes?

    Article • ARC Journal of Cardiology, January 2017, ARC Publications Pvt Ltd.

    Professor Alexander E Berezin

  203. Novel Biomarkers for Cardiovascular Risk in Obese Patients

    Article • Journal of Cardiology and Therapy, January 2017, ACT Publishing Group

    Professor Alexander E Berezin

  204. Combined methods for micro particles determining: are they useful?

    Article • Biological Markers and Guided Therapy, January 2017, Hikari, Ltd.

    Professor Alexander E Berezin

  205. Osteopontin in Vascular Calcification: A Central Player or Accidental Witness?

    Article • Medicinal Chemistry, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  206. Coupling Analytical Methods for Detection of Microparticles: The Possibilities for Improvement

    Article • Journal of Biotechnology & Biomaterials, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  207. Preconditioned Endothelial Progenitor Cells as Biomarker of Vascular Reparation?

    Article • Insights in Biomedicine, January 2017, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  208. Progenitor Cell Dysfunction: The Role of Endothelial Precursors in Heart Failure

    Article • Journal of Biomedical Sciencies, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  209. Endothelial Repair and Endothelial Cell-Derived Secretome

    Article • January 2017, Heighten Science Publications Corporation

    Professor Alexander E Berezin

  210. Biomarkers in Heart Failure

    Article • Journal of Blood & Lymph, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  211. Biosensing of red blood cell-derived extracellular vesicles with the advanced bright-field light optical polarization microscopy

    Article • International Journal of Biotechnology and Bioengineering, January 2017, Biocore Group

    Professor Alexander E Berezin

  212. Bone-Related Proteins as Markers in Vascular Remodeling

    Article • January 2017, Springer Science + Business Media

    Professor Alexander E Berezin

  213. New Trends in Stem Cell Transplantation in Diabetes Mellitus Type I and Type II

    Article • January 2017, Springer Science + Business Media

    Professor Alexander E Berezin

  214. Novel Biomarkers at Risk Stratification of Diabetes Mellitus Patients

    Article • January 2017, Springer Science + Business Media

    Professor Alexander E Berezin

  215. The Advanced Bright-field Light Optical Polarization Microscopy: Novel Coupling Method for Detection of Micro Vesicles

    Article • Journal of Medical Diagnostic Methods, January 2017, OMICS Publishing Group

    Professor Alexander E Berezin

  216. The altered vascular reparation in heart failure: the controversial role of endothelial progenitor cell dysfunction

    Article • Biological Markers and Guided Therapy, January 2017, Hikari, Ltd.

    Professor Alexander E Berezin

  217. Epigenetics in heart failure phenotypes

    Article • BBA Clinical, December 2016, Elsevier

    Professor Alexander E Berezin

  218. Cardiac biomarkers in diabetes mellitus: New dawn for risk stratification?

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, December 2016, Elsevier

    Professor Alexander E Berezin

  219. An association of serum vistafin level and number of circulating endothelial progenitor cells in type 2 diabetes mellitus patients

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, October 2016, Elsevier

    Professor Alexander E Berezin

  220. Acute Cardiovascular Care 2016

    Article • European Heart Journal Acute Cardiovascular Care, October 2016, Oxford University Press (OUP)

    Professor Alexander E Berezin

  221. Biomarkers for cardiovascular risk in patients with diabetes

    Article • Heart, September 2016, BMJ

    Professor Alexander E Berezin

  222. Links Between Concentrations of Serum 25-hydroxyvitamin D3 and the Numbers of Circulating Progenitor Mononuclear Cells in Patients With Metabolic Syndrome

    Article • Research in Cardiovascular Medicine, August 2016, Kowsar Medical Institute

    Professor Alexander E Berezin

  223. Endothelial progenitor cells dysfunction and impaired tissue reparation: The missed link in diabetes mellitus development

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, August 2016, Elsevier

    Professor Alexander E Berezin

  224. Is rationale to decrease serum osteoprotegerin and fetuin-A in type 2 diabetes mellitus patients?

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, July 2016, Elsevier

    Professor Alexander E Berezin

  225. Poster session 2Morphogenetic mechanisms290MiR-133 regulates retinoic acid pathway during early cardiac chamber specification291Bmp2 regulates atrial differentiation through miR-130 during early heart looping formationDevelopmental genetics294Associati...

    Article • Cardiovascular Research, July 2016, European Society of Cardiology

    Professor Alexander E Berezin

  226. Data regarding association between serum osteoprotegerin level, numerous of circulating endothelial- derived and mononuclear-derived progenitor cells in patients with metabolic syndrome

    Article • Data in Brief, June 2016, Elsevier

    Professor Alexander E Berezin

  227. PS105 Impaired Immune Phenotype of Circulating Endothelial-Derived Microparticles in None-Diabetic Patients with Chronic Heart Failure

    Article • Global Heart, June 2016, Ubiquity Press, Ltd.

    Professor Alexander E Berezin

  228. Is the neutrophil extracellular trap-driven microvascular inflammation essential for diabetes vasculopathy?

    Article • Biomedical Research and Therapy, May 2016, Biomedical Research and Therapy

    Professor Alexander E Berezin

  229. Article • Diabetes Research and Treatment Open Access, May 2016, Aperito Online Publishing Private Limited

    Professor Alexander E Berezin

  230. Abstracts

    Article • European Journal of Heart Failure, May 2016, Wiley

    Professor Alexander E Berezin, Associate Professor Chantal Ski, Professor Massimo Bonacchi, Professor David R Thompson

  231. Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, April 2016, Elsevier

    Professor Alexander E Berezin

  232. EuroHeartCare 2016

    Article • European Journal of Cardiovascular Nursing, April 2016, Oxford University Press (OUP)

    Professor Alexander E Berezin

  233. Relation of osteoprotegerin level and numerous of circulating progenitor mononuclears in patients with metabolic syndrome

    Article • Biomedical Research and Therapy, February 2016, Springer Science + Business Media

    Professor Alexander E Berezin

  234. Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction

    Article • EBioMedicine, February 2016, Elsevier

    Professor Alexander E Berezin

  235. Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease

    Article • Journal of Biomedical Research, January 2016, Journal of Biomedical Research

    Professor Alexander E Berezin

  236. The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis

    Article • Acta Clinica Belgica, January 2016, Taylor & Francis

    Professor Alexander E Berezin

  237. Contributors

    Article • January 2016, Elsevier

    Professor Alexander E Berezin

  238. The Neutrophil Extracellular Traps: The Missed Link between Microvascular Inflammation and Diabetes?

    Article • Journal of Postgenomics Drug & Biomarker Development, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  239. Pattern of circulating endothelial-derived microparticles among chronic heart failure patients with dysmetabolic comorbidities: The impact of subclinical hypothyroidism

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, January 2016, Elsevier

    Professor Alexander E Berezin

  240. Impaired Immune Phenotype of Endothelial Cell-derived Micro Particles: The Missing Link between Diabetes-related States and Risk of Cardiovascular Complications?

    Article • Journal of Data Mining in Genomics & Proteomics, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  241. The Role of Circulating Myeloid-Related Protein Complex Calprotectin in Prediction of Heart Failure with Preserved Ejection Fraction

    Article • January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  242. The Rationality to Use of Galectin-3 as Target in Biomarker-Guided Therapy of Type 2 Diabetes Mellitus

    Article • Endocrinology & Metabolic Syndrome, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  243. The Biomarker Utility in Risk Stratification in an Ambulatory Heart Failure: ST2 or Galectin-3?

    Article • Journal of Cardiology and Therapy, January 2016, ACT Publishing Group

    Professor Alexander E Berezin

  244. Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers

    Article • Journal of Circulating Biomarkers, January 2016, SAGE Publications

    Professor Alexander E Berezin

  245. Aortic Stenosis: Predictive Value of Cardiac Biomarkers in Older Patients

    Article • Journal of Gerontology & Geriatric Research, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  246. Does Visfatin Predict Cardiovascular Complications in Metabolic Syndrome Patients?

    Article • Endocrinology & Metabolic Syndrome, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  247. Extracellular vesicles as novel delivery drug system in heart failure: from bench to bedside?

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  248. Elevated galectin-3 level predicts pulmonary artery hypertension

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  249. Molecular and biochemical mechanisms of mitochondrial dysfunction in spontaneously hypertensive rats

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  250. Predictive value of vistafin in metabolic syndrome patients: focus on cardiovascular complications

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  251. Single sample and serial measurements of osteoprotegerin level as a target of therapy in type 2 diabetes mellitus?

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  252. Circulating endothelial-derived apoptotic microparticles and insulin resistance in non-diabetic patients with chronic heart failure

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2016, De Gruyter

    Professor Alexander E Berezin

  253. Determination of early tumoricidal drug-induced cardiotoxicity with biological markers

    Article • Journal of Translational Science, January 2016, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  254. Can Osteoprotegerin be a Target of Therapy in Type 2 Diabetes Mellitus?

    Article • Journal of Postgenomics Drug & Biomarker Development, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  255. Non-Classical Progenitor Mononuclears in Metabolic Syndrome: The Role of Serum 25-Hydroxyvitamin D3

    Article • January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  256. Impaired Pattern of Endothelial Cell-Derived Microparticles in Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction

    Article • Journal of Molecular Biomarkers & Diagnosis, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  257. Progenitor Endothelial Cell Dysfunction in Heart Failure: Clinical Implication and Therapeutic Target?

    Article • Translational Medicine, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  258. Utilization of Novel Delivery Drug Systems Based on Release of Extracellular Vesicles in Heart Failure

    Article • Cell & Developmental Biology, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  259. Global Longitudinal Strain and Strain Rate in Type Two Diabetes Patients with Chronic Heart Failure: Relevance to Osteoprotegerin

    Article • Folia Medica, January 2016, De Gruyter

    Professor Alexander E Berezin, Dr. Ioana Mozos

  260. Genetic Predictive Scores in Heart Failure: Possibilities and Expectations

    Article • Journal of Data Mining in Genomics & Proteomics, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  261. Progenitor Endothelial Cell Dysfunction in Obese Patients: Possibilities for Cardiovascular Risk Prediction

    Article • Journal of Clinical & Experimental Cardiology, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  262. Altered endothelial reparation and diabetes-Induced endothelial progenitor cell dysfunction

    Article • Cardiovascular Disorders and Medicine, January 2016, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  263. Are Epigenetic Features Essential in Advance of Heart Failure Phenotypes?

    Article • Journal of Cardiology and Therapy, January 2016, ACT Publishing Group

    Professor Alexander E Berezin

  264. Blood pressure measurement assistance and antihypertensive drug compliance in older patients

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  265. Circulating Vascular Endothelial Growth Factor-1 in Cardiovascular Disease

    Article • January 2016, Springer Science + Business Media

    Professor Alexander E Berezin

  266. Endothelial Repair in Diabetes: The Causative Role of Progenitor Cells Dysfunction?

    Article • Journal of Clinical Epigenetics, January 2016, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  267. Epigenetic Mechanisms of Endothelial Progenitor Cell Dysfunction

    Article • Journal of Clinical Epigenetics, January 2016, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  268. Epigenetic Modifications the Development of Different Heart Failure Phenotypes

    Article • Journal of Data Mining in Genomics & Proteomics, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  269. Epigenetically Modified Endothelial Progenitor Cells in Heart Failure

    Article • Journal of Clinical Epigenetics, January 2016, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  270. Is Elevated Circulating Galectin-3 Level A Predictor of Pulmonary Artery Hypertension Development and Progression?

    Article • Clinical & Medical Biochemistry Open Access, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  271. Serum cystatin C and neutrophil gelatinase-associated lipocalin as biomarkers of glomerular and tubular kidney damage in patients with chronic glomerulonephritis and saved renal function

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  272. Serum interleukin-18 as a biomarker of tubular kidney damage in patients with chronic glomerulonephritis

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  273. The Cell-Free Mitochondrial DNA: A Novel Biomarker of Cardiovascular Risk?

    Article • Translational Biomedicine, January 2016, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  274. The Clinical Utility of Circulating Microparticles’ Measurement in Heart Failure Patients

    Article • Journal of Vascular Medicine & Surgery, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  275. Endothelial Progenitor Cell Dysfunction as a Biomarker of Cardiovascular Risk in Obese Patients

    Article • ARC Journal of Diabetes and Endocrinology, January 2016, ARC Publications Pvt Ltd.

    Professor Alexander E Berezin

  276. Different Obese Phenotypes and Progenitor Endothelial Cell Dysfunction: The Missed Link to Cardiovascular Risk

    Article • Annals of Clinical and Laboratory Research, January 2016, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  277. Utility of the Red Blood Cell-Derived Microparticles as a Marker of Periprocedural Adverse Effects amongst Patients with Acute ST-Segment Elevation Myocardial Infarction

    Article • Journal of Vascular Medicine & Surgery, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  278. The Endothelial Cell Secretome as a Factor of Endothelium Reparation: The Role of Microparticles

    Article • Journal of Metabolic Syndrome, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  279. The Promises, Methodological Discrepancies and Pitfalls in Measurement of Cell-Derived Extracellular Vesicles in Diseases

    Article • Journal of Biotechnology & Biomaterials, January 2016, OMICS Publishing Group

    Professor Alexander E Berezin

  280. The approaches to none-invasive detection of cell-derived extracellular vesicles

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  281. The heart failure risk predictive scores based on the genetic features: hope and hype

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  282. The risk stratification in heart failure patients: The controversial role of high-sensitive ST2

    Article • Journal of Integrative Cardiology, January 2016, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  283. The signature of circulating microparticles in heart failure patients with metabolic syndrome

    Article • Journal of Circulating Biomarkers, January 2016, SAGE Publications

    Professor Alexander E Berezin

  284. Biomarker-Guided Therapy for Chronic Heart Failure

    Article • January 2016, Springer Science + Business Media

    Professor Alexander E Berezin

  285. Endothelial progenitor cell-mediated vascular repair system in diabetes

    Article • Biological Markers and Guided Therapy, January 2016, Hikari, Ltd.

    Professor Alexander E Berezin

  286. C-Reactive Protein and Complements as an Acute Phase Response after Cardiac Surgery

    Article • ARC Journal of Cardiology, January 2016, ARC Publications Pvt Ltd.

    Professor Alexander E Berezin

  287. Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation

    Article • BBA Clinical, December 2015, Elsevier

    Professor Alexander E Berezin

  288. Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure

    Article • Biomedical Journal, December 2015, Elsevier

    Professor Alexander E Berezin

  289. Novel biomerker-based score for heart failure

    Article • Clinical Hypertension, December 2015, Springer Science + Business Media

    Professor Alexander E Berezin

  290. Predictive Value of Circulatingve-catherin in Coronary Artery Disease Patients with Symptomatic Moderate to Severe Chronic Heart Failure

    Article • Journal of Medicine, November 2015, Bangladesh Journals Online (BanglaJOL)

    Professor Alexander E Berezin

  291. Stable Coronary Artery Disease Patients: Different Practice Patterns in Everyday Clinical Situations

    Article • EBioMedicine, November 2015, Elsevier

    Professor Alexander E Berezin

  292. Endothelial Derived Micro Particles: Biomarkers for Heart Failure Diagnosis and Management

    Article • Journal of Clinical Trials in Cardiology, October 2015, Symbiosis Group

    Professor Alexander E Berezin

  293. Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, October 2015, Elsevier

    Professor Alexander E Berezin

  294. Impaired phenotype of circulating endothelial microparticles in chronic heart failure patients: Relevance to body mass index

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, October 2015, Elsevier

    Professor Alexander E Berezin

  295. The effect of angiotensin-2 receptor blocker valsartan on circulating level of endothelial progenitor cells in diabetic patients with asymptomatic coronary artery disease

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, October 2015, Elsevier

    Professor Alexander E Berezin

  296. The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients

    Article • Research in Cardiovascular Medicine, September 2015, Kowsar Medical Institute

    Professor Alexander E Berezin

  297. The Impact of Low-Grading Inflammation on Circulating Endothelial-Derived Progenitor Cells in Patients with Metabolic Syndrome and Diabetes Mellitus

    Article • Journal of Endocrinology and Diabetes, June 2015, Symbiosis Group

    Professor Alexander E Berezin

  298. Impaired Immune Phenotype of Circulating Endothelial-Derived Microparticles in None-Diabetic Patients with Chronic Heart Failure: Impact on Insulin Resistance

    Article • June 2015, Pak Publishing Group

    Professor Alexander E Berezin

  299. The predictive role of circulating microparticles in patients with chronic heart failure

    Article • BBA Clinical, June 2015, Elsevier

    Professor Alexander E Berezin

  300. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases

    Article • Clinical Biochemistry, June 2015, Elsevier

    Professor Alexander E Berezin

  301. [PP.36.09]

    Article • Journal of Hypertension, June 2015, Wolters Kluwer Health

    Professor Alexander E Berezin

  302. [PP.36.08]

    Article • Journal of Hypertension, June 2015, Wolters Kluwer Health

    Professor Alexander E Berezin

  303. Moderated Poster Session 2: Sunday 3 May 2015, 15:30-16:30 * Room: Moderated Poster Area

    Article • European Heart Journal - Cardiovascular Imaging, May 2015, European Society of Cardiology

    Professor Alexander E Berezin

  304. Poster Session 2: Monday 4 May 2015, 08:00-18:00 * Room: Poster Area

    Article • European Heart Journal - Cardiovascular Imaging, May 2015, European Society of Cardiology

    Professor Alexander E Berezin

  305. Poster Session 3: Tuesday 5 May 2015, 08:30-12:30 * Room: Poster Area

    Article • European Heart Journal - Cardiovascular Imaging, May 2015, European Society of Cardiology

    Professor Alexander E Berezin, Professor marija B Vavlukis

  306. Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients

    Article • Journal of Cardiology, May 2015, Elsevier

    Professor Alexander E Berezin

  307. Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus

    Article • Journal of Endocrinological Investigation, April 2015, Springer Science + Business Media

    Professor Alexander E Berezin

  308. Rational Synthesis of AB-Type N -Substituted Core-Functionalized Naphthalene Diimides (cNDIs)

    Article • Organic Letters, April 2015, American Chemical Society (ACS)

    Professor Alexander E Berezin

  309. Содержание циркулирующих эндотелиальных прогениторных клеток у пациентов с хронической сердечной недостаточностью ишемической природы с сохраненной фракцией выброса левого желудочка

    Article • Kardiologiia, January 2015, Bionika Media

    Professor Alexander E Berezin

  310. Circulating Vascular Endothelial Growth Factor-1 in Cardiovascular Disease

    Article • January 2015, Springer Science + Business Media

    Professor Alexander E Berezin

  311. The association of serum osteoprotegerin/ sRANKL complex, C-reactive protein and adiponectin with number of circulating endothelial progenitor cells in patients with metabolic syndrome and diabetes mellitus

    Article • Journal of Integrative Cardiology, January 2015, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  312. The Role of Cardiac Biomarkers in Predicting of Mortality in Diabetic Patients

    Article • Journal of Cardiology and Therapy, January 2015, ACT Publishing Group

    Professor Alexander E Berezin

  313. The Development of Biological Molecular Sensing Techniques to detect Micro particles: Focus on Clinical Medicine Benefits

    Article • Journal of Microbial & Biochemical Technology, January 2015, OMICS Publishing Group

    Professor Alexander E Berezin

  314. Complications of Pharmacological Spasm Provocation Tests

    Article • Angiology Open Access, January 2015, OMICS Publishing Group

    Professor Alexander E Berezin

  315. The Interplay of Aging, Aortic Stiffness and Blood Viscosity in Atherogenesis

    Article • Journal of Cardiology and Therapy, January 2015, ACT Publishing Group

    Professor Alexander E Berezin

  316. Transluminal endovascular aortic repair and pregnancy: a case report

    Article • Journal of Integrative Cardiology, January 2015, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  317. Inflammatory phenotype of circulating endothelial-derived microparticles in chronic heart failure patients with metabolic syndrome

    Article • Journal of Molecular Pathophysiology, January 2015, ScopeMed International Medical Journal Management and Indexing System

    Professor Alexander E Berezin

  318. Micro RNA as Biomarkers and Tool for Target-Based Treatment in Patients with Inflammatory Bowel Diseases

    Article • Biology and Medicine, January 2015, OMICS Publishing Group

    Professor Alexander E Berezin

  319. Immune Phenotypes of Endothelial-Derived Microparticles in Dysmetabolic Patients.

    Article • Journal of Proteomics & Bioinformatics, January 2015, OMICS Publishing Group

    Professor Alexander E Berezin

  320. Immune Phenotype of Circulating Endothelial-derived Microparticlesin Elderly Patients with Metabolic Syndrome and Diabetes Mellitus

    Article • Journal of Gerontology & Geriatric Research, January 2015, OMICS Publishing Group

    Professor Alexander E Berezin

  321. Vascular Endothelial Growth Factor-1 Level and Functional Neurologic Recovery after Ischemic Hemispheric Stroke

    Article • Neurochemistry & Neuropharmacology, January 2015, OMICS Publishing Group

    Professor Alexander E Berezin

  322. The Metabolic Effects of Mineralocorticoid Receptor Antagonists in Heart Failure Patients

    Article • Cardiovascular Pharmacology Open Access, January 2015, OMICS Publishing Group

    Professor Alexander E Berezin

  323. Prognostication of heart failure development and advance: the role of high-sensitive ST2

    Article • Integrative Molecular Medicine, January 2015, Open Access Text Pvt, Ltd.

    Professor Alexander E Berezin

  324. Impaired Phenotype of Circulating Endothelial-Derived Microparticles: Novel Marker of Cardiovascular Risk

    Article • Journal of Cardiology and Therapy, January 2015, ACT Publishing Group

    Professor Alexander E Berezin

  325. Circulating Cell-Free Mitochondrial DNA as Biomarker of Cardiovascular risk: New Challenges of Old Findings

    Article • Angiology Open Access, January 2015, OMICS Publishing Group

    Professor Alexander E Berezin

  326. Biomarker-Guided Therapy for Chronic Heart Failure

    Article • January 2015, Springer Science + Business Media

    Professor Alexander E Berezin

  327. Bone-Related Proteins as Markers in Vascular Remodeling

    Article • January 2015, Springer Science + Business Media

    Professor Alexander E Berezin

  328. Utility of Biomarkers in Contemporary Management of Chronic Heart Failure

    Article • Annals of Clinical and Laboratory Research, January 2015, Scitechnol Biosoft Pvt. Ltd.

    Professor Alexander E Berezin

  329. Cardiovascular Biomarkers in Routine Screening of Diabetic Pati ents

    Article • Clinical & Medical Biochemistry Open Access, January 2015, OMICS Publishing Group

    Professor Alexander E Berezin

  330. Early tumoricidal drug-induced cardiotoxicity determination: possibilities of biological markers

    Article • Biological Markers and Guided Therapy, January 2015, Hikari, Ltd.

    Professor Alexander E Berezin

  331. The Pattern of Circulating Microparticles in Diabetes Mellitus Patients with Known Subclinical Atherosclerosis

    Article • Clinical & Medical Biochemistry Open Access, January 2015, OMICS Publishing Group

    Professor Alexander E Berezin

  332. Signature of circulating endothelial-derived progenitor cells in patients with metabolic syndrome and diabetes mellitus

    Article • Biological Markers and Guided Therapy, January 2015, Hikari, Ltd.

    Professor Alexander E Berezin

  333. Cell therapy of chronic heart failure: perspective of clinical approach

    Article • Biological Markers and Guided Therapy, January 2015, Hikari, Ltd.

    Professor Alexander E Berezin

  334. The fixed combination of aliskiren and nebivolol in hypertensive patients: the clinical perspectives

    Article • Biological Markers and Guided Therapy, January 2015, Hikari, Ltd.

    Professor Alexander E Berezin

  335. Impact of age on pattern of circulating endothelial-derived microparticles in heart failure patients

    Article • Healthy Aging Research, January 2015, Longdom Group

    Professor Alexander E Berezin

  336. Predictive Value of Circulating SPARC-Related protein Osteonectin in Patients with Symptomatic Moderate-to-Severe Ischemic-Induced Chronic Heart Failure

    Article • International Journal of Cardiology and Lipidology Research, December 2014, Cosmos Scholars Publishing House

    Professor Alexander E Berezin

  337. The relationship between serum uric acid level and concentration of proangiogenic mononuclear progenitor cells in patients with chronic heart failure

    Article • Journal of Clinical and Experimental Investigations, December 2014, Association of Health Investigations

    Professor Alexander E Berezin

  338. Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, July 2014, Elsevier

    Professor Alexander E Berezin

  339. P202Interrelationship between circulating osteoprotegerin and subclinical coronary atherosclerosis in patients with type two diabetes mellitus

    Article • Cardiovascular Research, June 2014, European Society of Cardiology

    Professor Alexander E Berezin

  340. P194Serum uric acid as independent predictor of decreased number of circulating proangiogenic progenitor cells in asymptomatic coronary artery disease patients

    Article • Cardiovascular Research, June 2014, European Society of Cardiology

    Professor Alexander E Berezin

  341. Circulating Endothelial Progenitor Cells as Markers for Severity of Ischemic Chronic Heart Failure

    Article • Journal of Cardiac Failure, June 2014, Elsevier

    Professor Alexander E Berezin

  342. Impaired Pattern of Endothelial Derived Microparticles in Heart Failure Patients

    Article • Journal of Molecular and Genetic Medicine, January 2014, OMICS Publishing Group

    Professor Alexander E Berezin

  343. Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives

    Article • World Journal of Diabetes, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Professor Alexander E Berezin

  344. Serum Uric Acid Predicts Declining of Circulating Proangiogenic Mononuclear Progenitor Cells in Chronic Heart Failure Patients

    Article • Journal of Cardiovascular and Thoracic Research, January 2014, International Society for Phytocosmetic Scicences

    Professor Alexander E Berezin

  345. Serum Rankl/Osteoprotegerin Complex and Endothelial Progenitor Cells in Chronic Heart Failure

    Article • Journal of Diagnostics, January 2014, Pak Publishing Group

    Professor Alexander E Berezin

  346. Predictive Value of Circulating Vascular Endothelial Growth Factor-1 Level Measured Repeatedly During Long-Term Follow-Up in Patients with Arterial Hypertension after Acute Ischemic Stroke

    Article • Angiology Open Access, January 2014, OMICS Publishing Group

    Professor Alexander E Berezin

  347. Predictive Value of Circulating Apoptotic Microparticles in Patients with Ischemic Symptomatic Moderate-To-Severe Chronic Heart Failure

    Article • Angiology Open Access, January 2014, OMICS Publishing Group

    Professor Alexander E Berezin

  348. Apoptotic Microparticles as Predicted Biomarkers in Patients with Chronic Heart Failure – Relevance to Inflammatory Cytokines and Outcomes

    Article • Journal of Circulating Biomarkers, January 2014, IntechOpen

    Professor Alexander E Berezin

  349. C-reactive protein after stroke in arterial hypertension

    Article • Asian Cardiovascular and Thoracic Annals, October 2013, SAGE Publications

    Professor Alexander E Berezin

  350. Vascular endothelial growth factor-1 as a predictor of unfavorable cardiovascular events in arterial hypertension patients after ischemic stroke

    Article • Cardiologia Croatica, September 2013, Medical Publishing, d.o.o.

    Professor Alexander E Berezin

  351. Relationship between level of circulating endothelial progenitor cells and severity of ischemic chronic heart failure with preserved left ventricular ejection fraction

    Article • Cardiologia Croatica, September 2013, Medical Publishing, d.o.o.

    Professor Alexander E Berezin

  352. Predict value of circulating bone-related glycopeptide osteoprotegerin in asymptomatic coronary artery disease patients with second type diabetes mellitus

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Professor Alexander E Berezin

  353. Predict value of circulating endothelial progenitor cells in patients with moderate-to-severe chronic heart failure due to coronary artery disease

    Article • European Heart Journal, August 2013, European Society of Cardiology

    Professor Alexander E Berezin

  354. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease

    Article • Atherosclerosis, August 2013, Elsevier

    Professor Alexander E Berezin

  355. Analysis of Various Subsets of Circulating Mononuclear Cells in Asymptomatic Coronary Artery Disease

    Article • Journal of Clinical Medicine, July 2013, MDPI AG

    Professor Alexander E Berezin

  356. Oral Abstract Session: Novel non-invasive risk marker

    Article • EP Europace, June 2013, European Society of Cardiology

    Professor Alexander E Berezin

  357. Prognostic value of biological markers in myocardial infarction patients

    Article • Asian Cardiovascular and Thoracic Annals, April 2013, SAGE Publications

    Professor Alexander E Berezin

  358. Circulating endothelial progenitor cells as a predictor of clinical outcomes in diabetic patients with symptomatic chronic heart failure

    Article • Endocrine Abstracts, April 2013, Bioscientifica

    Professor Alexander E Berezin

  359. A potential predict value of circulating osteoprotegerin in diabetic patients with asymptomatic coronary artery disease

    Article • Endocrine Abstracts, April 2013, Bioscientifica

    Professor Alexander E Berezin

  360. Serum Uric Acid as a Marker of Coronary Calcification in Patients with Asymptomatic Coronary Artery Disease with Preserved Left Ventricular Pump Function

    Article • Cardiology Research and Practice, January 2013, Hindawi Publishing Corporation

    Professor Alexander E Berezin

  361. Predictive Value of Circulating Vascular Endothelial Growth Factor-1 in Arterial Hypertension Patients

    Article • Internal Medicine Open Access, January 2013, OMICS Publishing Group

    Professor Alexander E Berezin

  362. Bone-related circulating proteins as early predictors of coronary atherosclerosis in asymptomatic patients with known coronary artery disease

    Article • Advanced Studies in Medical Sciences, January 2013, Hikari, Ltd.

    Professor Alexander E Berezin

  363. Neuroprotective and memory enhancing properties of a dual agonist of the FGF receptor and NCAM

    Article • Neurobiology of Disease, December 2012, Elsevier

    Professor Alexander E Berezin

  364. Poster session 1

    Article • Cardiovascular Research, March 2012, European Society of Cardiology

    Dr Ajmal Gardiwal, Professor Alexander E Berezin

  365. Poster session 3

    Article • Cardiovascular Research, March 2012, European Society of Cardiology

    Dr Joseph Vettukattil, Professor Alexander E Berezin

  366. TRANSFORMING GROWTH FACTOR-BETA 1 AND HEART REMODELING IN TYPE 2 DIABETES MELLITUS PATIENTS ASSOCIATED WITH LEFT VENTRICULAR DIASTOLIC DYSFUNCTION

    Article • Journal of Hypertension, June 2011, Wolters Kluwer Health

    Professor Alexander E Berezin

  367. SIMVASTATIN IN ESCALATION DOSES IMPROVE RENAL FUNCTION IN PATIENTS WITH DIABETES MELLITUS AND MILD-TO-MODERATE PROTEINURIA

    Article • Journal of Hypertension, June 2011, Wolters Kluwer Health

    Professor Alexander E Berezin

  368. OSTEOPONTIN PLASMA LEVEL AS A TARGET IN THE ASSESSMENT OF SEVERITY HEART FAILURE AND CARDIAC REMODELLING

    Article • Journal of Hypertension, June 2011, Wolters Kluwer Health

    Professor Alexander E Berezin

  369. CIRCULATING STROMELYSIN-1 AS A POSSIBLE MARKER OF SEVERITY OF CARDIOVASCULAR REMODELING IN OBESITY PATIENTS AFTER MYOCARDIAL INFARCTION

    Article • Journal of Hypertension, June 2011, Wolters Kluwer Health

    Professor Alexander E Berezin

  370. Abstracts

    Article • European Heart Journal Supplements, April 2011, Oxford University Press (OUP)

    Professor Alexander E Berezin, Professor marija B Vavlukis

  371. Abstracts

    Article • European Heart Journal Supplements, October 2010, Oxford University Press (OUP)

    Professor Alexander E Berezin, Professor Margarita Giannakopoulou

  372. Saturday, 17 July 2010

    Article • Cardiovascular Research, June 2010, European Society of Cardiology

    Professor Alexander E Berezin

  373. Candesartan cilexitil reduces neurohumoral and proinflammatory activation in patients with severe congestive heart failure

    Article • European Journal of Heart Failure Supplements, June 2008, Oxford University Press (OUP)

    Professor Alexander E Berezin

  374. 774 Highly selective beta-1 blocker bisoprolol significantly improves long-term prognosis in asymptomatic heart failure patients

    Article • European Journal of Heart Failure Supplements, January 2006, Oxford University Press (OUP)

    Professor Alexander E Berezin

  375. 724 Low doses of statins improve neurohumoral activity in patients with moderate-to-severe congestive heart failure due to coronary artery disease

    Article • European Journal of Heart Failure Supplements, January 2006, Oxford University Press (OUP)

    Professor Alexander E Berezin

  376. 313 The interrelation between plasma level of natriuretic peptide and long-term prognosis about patients with congestive heart failure

    Article • European Journal of Heart Failure Supplements, June 2004, Oxford University Press (OUP)

    Professor Alexander E Berezin

  377. 166 Angiotensin-2 receptor blockade with losartan improves left ventricular function at rest and post-exercise in heart failure patients with preserved ejection fraction

    Article • European Journal of Heart Failure Supplements, June 2004, Oxford University Press (OUP)

    Professor Alexander E Berezin

  378. 470 Angiotensin-2 receptor blockade with losartan improves left ventricular function at rest and post-exercise in heart failure patients with preserved ejection fraction

    Article • European Journal of Heart Failure Supplements, June 2003, Oxford University Press (OUP)

    Professor Alexander E Berezin

  379. Losartan in the Therapy of Heart Failure Patients

    Article • Asian Cardiovascular and Thoracic Annals, December 2001, SAGE Publications

    Professor Alexander E Berezin

  380. 4.11 The interrelation between plasma level of atrial natriuretic peptide and long-term prognosis about patients with congestive heart failure

    Article • Journal of Nuclear Cardiology, January 2001, Springer Science + Business Media

    Professor Alexander E Berezin

  381. 4.10 Long-term administration of angiotensin-2 receptor antagonist losartan adding to ace inhibitor enalapril in patients with congestive heart failure

    Article • Journal of Nuclear Cardiology, January 2001, Springer Science + Business Media

    Professor Alexander E Berezin

  382. The dose-dependent influence of angiotensin-II receptor antagonist losartan on remodeling and neurohumoral status in patients with congestive heart failure

    Article • European Journal of Heart Failure, June 2000, Wiley

    Professor Alexander E Berezin

  383. Angiotensin-II receptor antagonist losartan improves the diastolic performance in patients with asymptomatic heart failure due to myocardial infarction

    Article • European Journal of Heart Failure, June 2000, Wiley

    Professor Alexander E Berezin

  384. Biological Markers and Guided Therapy

    Article • Biological Markers and Guided Therapy, Hikari, Ltd.

    Professor Alexander E Berezin